BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10260321)

  • 1. Hospitals can pull in extra 5% profit by marketing their slack lab capacity.
    Nathanson M
    Mod Healthc; 1983 May; 13(5):64, 67. PubMed ID: 10260321
    [No Abstract]   [Full Text] [Related]  

  • 2. The retainer fee contract.
    Schoen I
    Pathologist; 1981 Aug; 35(8):438-9. PubMed ID: 10252492
    [No Abstract]   [Full Text] [Related]  

  • 3. Zero base approach to fiscal management of the laboratory.
    Boudreau DA; Majonos JS
    Pathologist; 1985 Aug; 39(8):14-8. PubMed ID: 10272519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directing the post-TEFRA laboratory.
    Sharp JW
    Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating revenue through laboratory testing.
    Hannon F
    Hosp Entrep Newsl; 1987 Jun; 3(1):1-2, 8. PubMed ID: 10325197
    [No Abstract]   [Full Text] [Related]  

  • 6. Slow lab computer market picks up.
    LaViolette S
    Mod Healthc; 1979 Nov; 9(11):46, 48. PubMed ID: 492117
    [No Abstract]   [Full Text] [Related]  

  • 7. Avoid conflict: know the legal implications.
    Polk LT
    Pathologist; 1983 Aug; 37(8):546-8. PubMed ID: 10263502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologists hope HHS clarification will give them leverage with hospitals.
    Wallace C
    Mod Healthc; 1984 Jun; 14(8):28, 30. PubMed ID: 10273518
    [No Abstract]   [Full Text] [Related]  

  • 9. Instituting change to cut lab costs.
    Pelton TN
    Pathologist; 1985 Jul; 39(7):17-20. PubMed ID: 10272022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lab salaries and benefits. Part I: Are they keeping pace?
    Benezra N
    MLO Med Lab Obs; 1987 Jan; 19(1):30-4. PubMed ID: 10280450
    [No Abstract]   [Full Text] [Related]  

  • 11. COBRA coils for strike against clinical lab fees.
    MLO Med Lab Obs; 1986 Jun; 18(6):25-6. PubMed ID: 10300963
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenge of catastrophe.
    Dorsey DB
    Pathologist; 1978 Sep; 32(9):564-7. PubMed ID: 10308711
    [No Abstract]   [Full Text] [Related]  

  • 13. Lab salaries and benefits. Part II: Dissatisfaction in the ranks.
    Benezra N
    MLO Med Lab Obs; 1987 Jan; 19(1):37-9. PubMed ID: 10280451
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospitals for radical new cost rules.
    MLO Med Lab Obs; 1983 Jan; 15(1):27-8. PubMed ID: 10298828
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital finds how to keep pace with new lab technology--without outstripping budget.
    Geromini K
    Cost Containment; 1982 Feb; 4(3):7. PubMed ID: 10254751
    [No Abstract]   [Full Text] [Related]  

  • 16. Fulfilling Medicare's criteria for consultative services.
    Pastuszak WT
    Pathologist; 1985 Jun; 39(6):31-4. PubMed ID: 10300151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dr. Derman testifies on MD-DRGs.
    Derman H
    Pathologist; 1986 Aug; 40(8):51-4. PubMed ID: 10311691
    [No Abstract]   [Full Text] [Related]  

  • 18. What the regulatory developments mean for pathologist-hospital contracts.
    Bierig JR; Dechene JC
    Pathologist; 1984 Sep; 38(9):562-7. PubMed ID: 10273568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unordered test: cost of the benefit vs. benefit of the cost.
    Winkelman JW; Bernstein LH
    Pathologist; 1985 Jul; 39(7):12-6. PubMed ID: 10317618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legal considerations in pathologists' contracting-recent developments.
    Polk LT
    Pathologist; 1981 May; 35(5):268-71. PubMed ID: 10251158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.